TY  - JOUR

T1  - Assessing the costs and benefits of a pharmacogenetic test to reduce the incidence of adverse events

JO  - PHARMACOEPIDEMIOLOGY AND DRUG SAFETY

PY  - 2012/01/01

AU  - Shabaruddin FH

AU  - Elliott RA

AU  - Tappenden P

AU  - Payne K

ED  - 

VL  - 21

IS  - 1

SP  - 118

EP  - 118

Y2  - 2025/04/17

ER  -